Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Quick Stats
May 18, 202655.1
AI Score
HOLD0.85
Volume Ratio
May 05, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
SUPN Stock Summary
Last updated May 18, 2026
SUPN is currently trading at $48.33, positioned below its 200-day moving average of $48.62, suggesting bearish momentum. The stock has a 52-week range of $30.83 to $59.68.
Technical Analysis: The 50-day moving average stands at $50.26, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.485, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.072, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates SUPN at 55.1/100 with a HOLD recommendation.
SUPN (Supernus Pharmaceuticals, Inc.) Indicators
Last updated May 18, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 42.485 |
| CMF (20) | 0.072 |
| ROC (10) | -0.74 |
| ADX (14) | 12.649 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.108 |
| AROONOSC (14) | |
| WILLAMS %R (14) | -77.013 |
| MFI (14) | 62.935 |
SUPN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SUPN Price vs Max Options Open Interest
SUPN Max Change In Options Open Interest
SUPN Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SUPN Daily Out of Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SUPN Daily In the Money Options - Sort by Max open Interest (near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SUPN Most Active Options by Volume(near term)
18th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Supernus Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SUPN Moving Averages Analysis
SUPN (Supernus Pharmaceuticals, Inc.) Simple Moving Averages
Moving Averages are last updated May 18, 2026
| Days | MA |
|---|---|
| 10 | 50.47 |
| 20 | 49.77 |
| 30 | 50.07 |
| 50 | 50.26 |
| 100 | 50.67 |
| 200 | 48.62 |
SUPN Fundamental Analysis
| P/E (Forward) | 20.1613 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.0 billion |
| Earnings/Share ($) | -0.51 |
| Net Proft Margin (%) | -0.0374 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 2.675 |
| EPS Estimate Next Year ($) | 4.3667 |
| WallStreet Target Price ($) | 62.8333 |
| Most Recent Quarter |